Class II · Moderate risk
Detoxin-S
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
FDA Drug Recalls
18,003 recalls, newest first
Class II · Moderate risk
Detoxin Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
DeTensin Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Dermatoxin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Dermamycin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
De-Fibroidin
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Cellulite Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Blood Clot Purger
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Bleeding Stop
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Asthma Chest Rub
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Asma Stopper
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Age Stop Ex
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Age Back
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Acne Off
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Acne Cystic
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class II · Moderate risk
Acupuncture
CGMP Deviations: These products have been found to be misbranded as unapproved new drugs
Class I · High risk
Tetracycline HCL Capsules
Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.
Class I · High risk
Tetracycline HCL Capsules
Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.
Class III · Low risk
Tacrolimus Capsules
Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.
Class II · Moderate risk
Dermatone (avobenzone, homosalate, octisalate, and octocrylene)
Microbial contamination of non-sterile products: positive test for yeast and bacteria.
Class II · Moderate risk
Dermatone (avobenzone, homosalate, octisalate, and octocrylene)
Microbial contamination of non-sterile products: positive test for yeast and bacteria.
Class II · Moderate risk
Draximage Dtpa
Failed Stability Specifications
Class II · Moderate risk
Nystatin Oral Suspension
SubPotent Drug: Low out-of-specification results for assay testing.
Class II · Moderate risk
Ceftazidime Sterile Ophthalmic Solution for Injection Preservative Free 11.25mg / 0.5ml
Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.
Class II · Moderate risk
Methotrexate
Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.